These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 8069852)

  • 1. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Greenblatt MS; Bennett WP; Hollstein M; Harris CC
    Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 tumor-suppressor gene: clues to molecular carcinogenesis.
    Wang XW; Harris CC
    J Cell Physiol; 1997 Nov; 173(2):247-55. PubMed ID: 9365531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.
    Martin AC; Facchiano AM; Cuff AL; Hernandez-Boussard T; Olivier M; Hainaut P; Thornton JM
    Hum Mutat; 2002 Feb; 19(2):149-64. PubMed ID: 11793474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
    Wang XW; Harris CC
    Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 tumour suppressor gene and product.
    Levine AJ
    Cancer Surv; 1992; 12():59-79. PubMed ID: 1638548
    [No Abstract]   [Full Text] [Related]  

  • 8. The p53 story: layers of complexity.
    Braithwaite AW; Royds JA; Jackson P
    Carcinogenesis; 2005 Jul; 26(7):1161-9. PubMed ID: 15817608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
    Hainaut P
    Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
    [No Abstract]   [Full Text] [Related]  

  • 10. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.
    De Benedetti VM; Travis LB; Welsh JA; van Leeuwen FE; Stovall M; Clarke EA; Boice JD; Bennett WP
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):93-8. PubMed ID: 8850268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53: balancing tumour suppression and implications for the clinic.
    Buganim Y; Rotter V
    Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perspectives of practical application for studies of gene p53].
    Schlichtholz B; Soussi T
    Postepy Biochem; 1994; 40(4):211-21. PubMed ID: 7845878
    [No Abstract]   [Full Text] [Related]  

  • 17. [DNA damage-induced signal pathway of p53 as a tumor suppressor and the gene mutation in human cancer].
    Tsuchida N; Gao C; Tsuchida Y; Nakajima T; Nishigaki R
    Tanpakushitsu Kakusan Koso; 2000 Jul; 45(10):1742-51. PubMed ID: 10897687
    [No Abstract]   [Full Text] [Related]  

  • 18. p53--a natural cancer killer: structural insights and therapeutic concepts.
    Römer L; Klein C; Dehner A; Kessler H; Buchner J
    Angew Chem Int Ed Engl; 2006 Oct; 45(39):6440-60. PubMed ID: 16983711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology of tobacco smoke associated neoplasia].
    Zojer N; Fritsche R; Fiegl M; Schulte-Hermann R; Mannhalter C; Huber H
    Wien Klin Wochenschr; 1996; 108(18):574-81. PubMed ID: 9012141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.